Hydrocodone (HC) is a highly misused prescription drugs in the USA. Interpretation of urine tests for HC is complicated by its metabolism to two metabolites, hydromorphone (HM) and dihydrocodeine (DHC), which are also available commercially and are misused. Currently, there is interest in including HC and HM in the federal workplace drug-testing programs. This study characterized the disposition of HC in human urine. Twelve healthy, drug-free, adults were administered a single, oral 20 mg immediate-release dose of HC in a controlled clinical setting. Urine specimens were collected at timed intervals for up to 52 h and analyzed by LC-MS-MS (limit of quantitation = 50 ng/mL) with and without enzymatic hydrolysis. All specimens were also analyzed for creatinine and specific gravity (SG). HC and norhydrocodone (NHC) appeared within 2 h followed by HM and DHC. Peak concentrations of HC and metabolites occurred at 3-9 h. Peak hydrolyzed concentrations were in the order: NHC > HC > HM > DHC. Only HM was excreted extensively as a conjugated metabolite. At a cutoff concentration of 50 ng/mL, detection times were ∼28 h for HC, 40 h for NHC, 26 h for HM and 16 h for DHC. Some specimens did not contain HC, but most contained NHC, thereby facilitating interpretation that HC was the administered drug. Creatinine and SG measures were highly correlated. Creatinine corrections of HC urinary data had variable effects of lowering or raising concentrations. These data suggest that drug-testing requirements for HC should include a hydrolysis step and a test for HM.

Download full-text PDF

Source
http://dx.doi.org/10.1093/jat/bkt066DOI Listing

Publication Analysis

Top Keywords

nhc dhc
8
prescription opioids
4
opioids metabolism
4
metabolism excretion
4
excretion patterns
4
patterns hydrocodone
4
urine
4
hydrocodone urine
4
urine controlled
4
controlled single-dose
4

Similar Publications

Targeting 7-dehydrocholesterol reductase against EV-A71 replication by upregulating interferon response.

Antiviral Res

January 2023

CAMS Key Laboratory of Antiviral Drug Research, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Science, Beijing, China. Electronic address:

Recent studies have shown a close link between viral infections and cholesterol metabolism. Here, we reported that 7-dehydrocholesterol reductase (DHCR7), a terminal enzyme for catalyzing cholesterol synthesis in the Kandutsch-Russell pathway, is harnessed by enterovirus A71 (EV-A71) benefitting for its replication. Overexpression of DHCR7 resulted in upregulating of EV-A71 replication, while the S14A mutation, which reduces DHCR7 enzyme activity, has no effect on EV-A71 replication.

View Article and Find Full Text PDF

Decompressive hemicraniectomy for acute ischemic stroke in a patient implanted with a left ventricular assist device: a case report.

BMC Cardiovasc Disord

June 2020

Pôle Anesthésie Réanimation Chirurgicale, service de Réanimation Chirurgicale, Hôpitaux Universitaires de Strasbourg NHC, 1, Place de l'Hôpital, 67000, Strasbourg, France.

Article Synopsis
  • Thromboembolic ischemic stroke (IS) is a serious risk following the placement of a left ventricular assist device (LVAD), complicating surgical treatment due to the use of anticoagulants.
  • A 39-year-old man experienced cardiogenic shock and underwent LVAD placement, but developed acute neurological deficits indicative of IS, which was confirmed by a CT scan; he then underwent emergency decompressive hemicraniectomy.
  • The case highlights that a careful approach to anticoagulation and teamwork in managing post-stroke care following LVAD surgery can lead to improved patient outcomes, including eventual heart transplantation.
View Article and Find Full Text PDF

The structures, energies, and rearrangements of imidoylnitrenes H-C(═NH)-N, HN-C(═NH)-N, Ph-C(═NH)-N, H-C(═NPh)-N, and MeO-C(═NCN)-N (10a-e) are investigated at DFT and CASPT2 levels of theory. Imidoylnitrenes are potentially formed by pyrolysis or photolysis of azides, tetrazoles (6, 6'), or sydnones. Unlike most acylnitrenes, the imidoylnitrenes 10 have triplet ground states.

View Article and Find Full Text PDF

Prescription Opioids. IV: Disposition of Hydrocodone in Oral Fluid and Blood Following Single-Dose Administration.

J Anal Toxicol

September 2015

Division of Workplace Programs, Substance Abuse and Mental Health Services Administration, Rockville, MD, USA.

The Substance Abuse and Mental Health Services Administration (SAMHSA) is currently evaluating hydrocodone (HC) for inclusion in the Mandatory Guidelines for Federal Workplace Drug Testing Programs. This study evaluated the time course of HC, norhydrocodone (NHC), dihydrocodeine (DHC) and hydromorphone (HM) in paired oral fluid and whole blood specimens by liquid chromatography-tandem mass spectrometry (limit of quantitation = 1 ng/mL of oral fluid, 5 ng/mL of blood) over a 52-h period. A single dose of HC bitartrate, 20 mg, was administered to 12 subjects.

View Article and Find Full Text PDF

Hydrocodone (HC) is a highly misused prescription drugs in the USA. Interpretation of urine tests for HC is complicated by its metabolism to two metabolites, hydromorphone (HM) and dihydrocodeine (DHC), which are also available commercially and are misused. Currently, there is interest in including HC and HM in the federal workplace drug-testing programs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!